Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Mometasone Furoate/Formoterol in Persistent Asthma
NCT00381485Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jul 2006
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of mometasone furoate + formoterol fumarate in asthma (3 arms), sponsored by Organon & Co. Primary endpoint: Area Under the Curve from 0 to 12 hours of the change from Baseline to Week 12 in Forced Expiratory Volume in 1 Second. Started Jul 2006; status: completed.
02
Drugs
mometasone furoate + formoterol fumarate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00381485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381485.